Biorelate offers free access to AI-based drug discovery tool: Galactic
The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights
The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights
People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus
Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials
The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour
COVID-19 molecular diagnostic and serology antibody testing at core of new suite of services
Ms. Knauer received a certificate signed by the German Federal Minister of Economics and Energy Peter Altmaier
Download this white paper from Sartorius to discover how enhanced data analytics and translational models can provide new biological insights
As a cryogenic supplier, Air Products looks at both modes of sample storage and compares them in terms of accessibility, reliability and temperature
The company aims to ramp up its production capacity of more than 50 million antibody tests per month
Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments
Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers
COVID-DPR is a virtual collection of high-resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health
Platform to complement Rentschler’s cell line development offering for difficult-to-express proteins
A qualitative test for the detection of nucleic acid from SARS-CoV-2
Onxeo to present new preclinical data at AACR 2020 illustrating the ability of AsiDNA™
Study suggests that type I IFN deficiency in the blood could help define a high-risk population